CureVac N.V. (CVAC) repots Q3 results

CureVac N.V. (NASDAQ: CVAC) reported Q3 results. Revenue for the quarter came in at $11.2 million versus the consensus estimate of $20.33 million.

For earnings history and earnings-related data on CureVac N.V. (CVAC) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
• Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c